These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9886808)

  • 1. AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation.
    Aslam F; McCabe L; Frenkel B; van Wijnen AJ; Stein GS; Lian JB; Stein JL
    Endocrinology; 1999 Jan; 140(1):63-70. PubMed ID: 9886808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
    Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine.
    Desai RK; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Endocrinology; 1995 Dec; 136(12):5685-93. PubMed ID: 7588324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors.
    Liu M; Freedman LP
    Mol Endocrinol; 1994 Dec; 8(12):1593-604. PubMed ID: 7708050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene.
    Guo B; Aslam F; van Wijnen AJ; Roberts SG; Frenkel B; Green MR; DeLuca H; Lian JB; Stein GS; Stein JL
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):121-6. PubMed ID: 8990171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in vitamin D receptor transcription factor complexes associated with the osteocalcin gene vitamin D responsive element in osteoblasts and osteosarcoma cells.
    Shakoori AR; van Wijnen AJ; Bortell R; Owen TA; Stein JL; Lian JB; Stein GS
    J Cell Biochem; 1994 Jun; 55(2):218-29. PubMed ID: 8089197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor.
    Mackey SL; Heymont JL; Kronenberg HM; Demay MB
    Mol Endocrinol; 1996 Mar; 10(3):298-305. PubMed ID: 8833658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells.
    Paredes R; Arriagada G; Cruzat F; Villagra A; Olate J; Zaidi K; van Wijnen A; Lian JB; Stein GS; Stein JL; Montecino M
    Mol Cell Biol; 2004 Oct; 24(20):8847-61. PubMed ID: 15456860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
    Matkovits T; Christakos S
    Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element.
    Hsieh JC; Whitfield GK; Jurutka PW; Haussler CA; Thatcher ML; Thompson PD; Dang HT; Galligan MA; Oza AK; Haussler MR
    Endocrinology; 2003 Nov; 144(11):5065-80. PubMed ID: 12960019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoid-X-receptor-alpha-independent binding of vitamin D receptor to its response element from human osteocalcin gene.
    Jääskeläinen T; Itkonen A; Mäenpää PH
    Eur J Biochem; 1995 Mar; 228(2):222-8. PubMed ID: 7705332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
    Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A
    Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
    Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
    Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha,25-dihydroxy vitamin D3-enhanced expression of the osteocalcin gene involves increased promoter occupancy of basal transcription regulators and gradual recruitment of the 1alpha,25-dihydroxy vitamin D3 receptor-SRC-1 coactivator complex.
    Carvallo L; Henríquez B; Paredes R; Olate J; Onate S; van Wijnen AJ; Lian JB; Stein GS; Stein JL; Montecino M
    J Cell Physiol; 2008 Mar; 214(3):740-9. PubMed ID: 17786964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
    J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: requirement of upstream sequences for control by the proximal regulatory domain.
    Frenkel B; Montecino M; Green J; Aslam F; Desai R; Banerjee C; Stein JL; Lian JB; Stein GS
    Endocrinology; 1996 Mar; 137(3):1080-88. PubMed ID: 8603577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.